MX2015009914A - Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. - Google Patents

Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Info

Publication number
MX2015009914A
MX2015009914A MX2015009914A MX2015009914A MX2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A
Authority
MX
Mexico
Prior art keywords
blood collection
inhibitor
collection devices
devices containing
contact pathway
Prior art date
Application number
MX2015009914A
Other languages
English (en)
Spanish (es)
Inventor
Keith A Moskowitz
Frank L Sinquett
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MX2015009914A publication Critical patent/MX2015009914A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/042—Caps; Plugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Clinical Laboratory Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)
MX2015009914A 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. MX2015009914A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759742P 2013-02-01 2013-02-01
PCT/US2014/014089 WO2014121041A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Publications (1)

Publication Number Publication Date
MX2015009914A true MX2015009914A (es) 2015-09-25

Family

ID=51259520

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009914A MX2015009914A (es) 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Country Status (12)

Country Link
US (1) US20140220552A1 (enExample)
EP (1) EP2950718A4 (enExample)
JP (1) JP2016505159A (enExample)
KR (1) KR20150141940A (enExample)
CN (1) CN105188535A (enExample)
AU (1) AU2014212194A1 (enExample)
BR (1) BR112015018077A2 (enExample)
CA (1) CA2899594A1 (enExample)
MX (1) MX2015009914A (enExample)
RU (1) RU2015136025A (enExample)
SG (1) SG11201505978PA (enExample)
WO (1) WO2014121041A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4234583A3 (en) 2013-01-20 2024-01-24 Takeda Pharmaceutical Company Limited Evaluation and treatment of bradykinin-mediated disorders
CA2927695C (en) 2013-10-21 2022-03-01 Dyax Corp. Diagnosis and treatment of autoimmune diseases
WO2015061183A1 (en) 2013-10-21 2015-04-30 Dyax Corp. Assays for determining plasma kallikrein system biomarkers
JP6758661B2 (ja) * 2015-05-14 2020-09-23 ゼネラル・エレクトリック・カンパニイ 血漿の分離および回収のためのキット
JP6907188B2 (ja) * 2015-08-13 2021-07-21 ダイアックス コーポレーション 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管
EP4354146B1 (en) * 2015-10-19 2026-04-15 Takeda Pharmaceutical Company Limited Immunoassay for the detection of cleaved high molecular weight kininogen
WO2017119508A1 (ja) * 2016-01-07 2017-07-13 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂
JP7649105B2 (ja) * 2017-07-21 2025-03-19 アムジエン・インコーポレーテツド 薬物容器のためのガス透過性シーリング部材及び組立方法
US12485412B2 (en) * 2021-08-05 2025-12-02 Lance Liberti Kit including biotin for harvesting platelet-rich plasma
CN115555070B (zh) * 2022-10-18 2024-11-05 北京积水潭医院 一种prf离心管
GB202219505D0 (en) * 2022-12-22 2023-02-08 Turzi Antoine Medical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064622A1 (en) * 1998-06-08 1999-12-16 University Of Vermont And State Agriculture College Inhibition of coagulation in blood and blood products
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
JP4496407B2 (ja) * 2002-05-13 2010-07-07 ベクトン・ディキンソン・アンド・カンパニー プロテアーゼ阻害剤試料採取システム
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
WO2005017486A2 (en) * 2003-06-09 2005-02-24 Mann Kenneth G A global test of the hemostatic system
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
JP2011504371A (ja) * 2007-11-21 2011-02-10 オレゴン ヘルス アンド サイエンス ユニバーシティー 抗第ｘｉ因子モノクローナル抗体およびその使用方法
EP2645932B1 (en) * 2010-12-02 2016-03-02 Becton, Dickinson and Company Blood collection devices containing blood stabilization agent
US9352016B2 (en) * 2011-03-09 2016-05-31 Csl Behring Gmbh Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces

Also Published As

Publication number Publication date
CA2899594A1 (en) 2014-08-07
EP2950718A4 (en) 2016-09-21
BR112015018077A2 (pt) 2017-07-18
WO2014121041A1 (en) 2014-08-07
SG11201505978PA (en) 2015-08-28
KR20150141940A (ko) 2015-12-21
US20140220552A1 (en) 2014-08-07
JP2016505159A (ja) 2016-02-18
AU2014212194A1 (en) 2015-09-17
EP2950718A1 (en) 2015-12-09
CN105188535A (zh) 2015-12-23
RU2015136025A (ru) 2017-03-06

Similar Documents

Publication Publication Date Title
MX2015009914A (es) Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.
NI201500103A (es) Anticuerpos cd47 que no agotan plaquetas ni glóbulos rojos y métodos de uso de los mismos.
CO2018000668A2 (es) Nuevos compuestos bicíclicos como inhibidores duales de atx/ca
CL2018003282A1 (es) Métodos y composiciones para el tratamiento de cánceres resistentes a los inhibidores de la vía no erk mapk
MX2016013963A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
CO2018000631A2 (es) Compuestos bicíclicos como inhibidores de atx
ECSP14006696A (es) Agentes de reversión anticoagulante
MX380146B (es) Inhibidores mk2 y usos de los mismos.
MX2018003353A (es) Terapias con celulas cart con una eficacia mejorada.
DOP2015000269A (es) Composiciones y métodos para alterar la señalización del segundo mensajero
CL2018002334A1 (es) Moduladores de complementos factor b (divisional solicitud 201600606)
MX2016007972A (es) Metodos para tratar canceres con antagonistas de union al eje pd-1 y taxanos.
MD20150100A2 (ro) Virusurile bolii de Newcastle şi utilizarea acestora
CR20160419A (es) Nuevos compuestos biciclicos
AR097481A1 (es) Cocristales energéticos para el tratamiento de una formación subterránea
UY34234A (es) Inhibidores de la replicación de los virus de la gripe
CR20150277A (es) Piridina-2-amidas utiles como agonistas cb2
CL2018000649A1 (es) Nuevos compuestos bicíclicos como inhibidores duales de atx / ca
MX2016004118A (es) Sistemas y metodos para asignacion dinamica para localidad y equilibrio.
UY34132A (es) Terapias combinadas para el tratamiento de neoplasias malignas hematológicas utilizando inhibidores de piridopirimidinona de pi3k/mtor con bendamustina y/o rituximab.
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
UY37258A (es) AGENTES REVERSORES DE UNIÓN PARA ANTICUERPOS ANTI-FACTOR XI/XIa Y SUS USOS
CR20150440A (es) Nuevos derivados de piridina
CL2016001266A1 (es) Nuevo octahidro-ciclobuta[1,2-c;3,4-c']dipirrol-2-ilo.
TR201902156T4 (tr) Bir kazıyıcı koruyucu palete yönelik palet zincir baklasında değişken sertleşme derinliği.